Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Gynecologic Cancer Gynecologic Cancer for January/February 2021 ‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer, More must reads Gynecologic Cancer for November/December 2020 Is diagnostic hysteroscopy safe in patients with type 2 endometrial cancer?, Cervical cancer recurrence patterns differ after laparoscopic and open hysterectomy, Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest, Half of women treated for gynecologic cancers miss or skip doses of oral drugs, New cancer drugs may have saved more than 1.2 million Americans, More must readsGynecologic Cancer for September/October 2020 ‘Tour de force’ study reveals therapeutic targets in 38% of cancer patients, Atezolizumab strikes out in ovarian cancer, Palbociclib plus letrozole improves PFS in advanced endometrial cancer, Survey quantifies COVID-19’s impact on oncology, Gene signature may improve prognostication in ovarian cancer, More must readsGynecologic Cancer for July/August 2020 VTE, sepsis risk increased among COVID-19 patients with cancer, Aspirin may accelerate cancer progression in older adults, ACS disagrees with CDC on HPV vaccination in adults, CCC19, other registries help define COVID-19/cancer landscape, Analysis of early onset cancers suggests need for genetic testing, More must readsGynecologic Cancer for May/June 2020 Personalized cancer vaccine may enhance checkpoint inhibitor activity, Sequential chemoradiation improves DFS in early-stage cervical cancer, Vulvar melanoma is increasing in older women, Secondary surgery extends OS in recurrent ovarian cancer, Video coaching may relieve anxiety and distress for long-distance cancer caregivers, More must readsPages1 2 3 4 5 6 last »
